Impact of Nirsevimab in Its Second Season on Respiratory Syncytial Virus and Non-RSV Admissions in Children Under 5
Universal nirsevimab immunization was associated with sustained reductions in RSV-related hospitalizations and critical illness, but also in hospitalizations due to other respiratory viruses.
Authors
- E. Parada (ORCID: https://orcid.org/0000-0002-1696-036X)
- Maria del Mar Albújar-Font
- Ana Aparisi-Esteve
- David Aragonès-Zabalza
- Xavier Viñas-Fernández
- Marina Rodriguez-Hidalgo
- Carmen Paima-Miguel
- Gabriel Zarauza-Pellejero
- Núria Lledó-Gras
Institutions
- Institut de Recerca Biomèdica Catalunya Sud (ES)
- Hospital Universitari Joan XXIII de Tarragona (ES)
- Universitat Rovira i Virgili (ES)
Publication Details
- Journal
- The Pediatric Infectious Disease Journal
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1097/inf.0000000000005059
- Citations
- 1
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 1.35